Ledger.Open graph →
SEC Form D · filed June 13, 2023

Kanvas Biosciences, Inc

Offering
$12.0M
Sold
$11.8M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
MONMOUTH JUNCTION, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Matthew Cheng · Monmouth Junction, NJExec · DirectorHao Shi · Monmouth Junction, NJExec · DirectorJason Pontin · Monmouth Junction, NJDirectorJustin Smithline · NEW YORK, NYDirectorDaorong Huang · Roslyn, NYExec · DirectorSuhrid Mantravadi · Dallas, TXExec · DirectorJohn Howard · Dallas, TXDirectorIwijn De Vlaminck · Monmouth Junction, NJExec · DirectorVijay S. Pelaprolu · Plano, TXDirectorSambasiva R. Jastipoorna · Plano, TXExec · DirectorBenjamin C. Taylor · Nicholasville, KYExec · DirectorIwijn De Vlaminck · Monmouth Junction, NJExec · DirectorJustin Smithline · East Hanover, NJDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗